Stress Coping Training for Nurses and Diabetes Control (SCT/T2MD/GLYCO)
Effectiveness of Psychological Stress and Coping Mechanism Training Program for Nurses and Its Impact on Glycemic Control Among Patients With Type 2 Diabetes Mellitus at the Hail Region
General Objectives
- To measure the effectiveness of the stress and coping mechanism training program that is meant to help nurses deal with occupational stress and at the same time provide healthcare services to Type 2 Diabetes Mellitus patients in the Hail Region.
- To find out the impact of increased ability of nurses to cope with stress and its consequences on blood glucose levels and health of patients with Type 2 Diabetes Mellitus.
- To explore the connection between nurses' psychological state and quality of the care offered to diabetic patients in the region.
- To examine the long-term effects of stress management techniques on the performance, emotional state, and engagement of nurses.
- To explore how training in stress and coping mechanisms could affect the establishment of an empathic environment that would make the patients adhere to diabetes management programs.
- To provide inputs into the elaboration of integrated healthcare programs that would take into consideration both psychological resilience of nurses and physiological stability of patients with diabetes and other chronic diseases.
Specific Objectives
- To measure occupational stress experienced by the nurses before and after attending a training course on psychological stress and coping methods.
- To determine the impact of the nurses' training program on patients' glucose control by measuring HbA1c.
- To determine the relationship between the coping methods used by the nurses and adherence of patients to medications, diet and other self-management practices.
- To find out the main coping methods used by the nurses which help to reduce stress and promote positive mood while providing nursing care to diabetic patients.
- To learn patients' perception of the quality of care and communication after attending the nurses' training program on psychological stress and coping mechanisms.
- To make recommendations about implementing the psychological training and stress management programs into the continuing professional education of nurses working in diabetes care units in Hail Region.
Research Questions
- What is the efficiency of the program aimed at the development of coping and stress training of nurses working with Type 2 Diabetes Mellitus patients in the Hail Region?
- Is there any effect of improved stress management skills of nurses on the level of glycemic control of their patients, which is measured in terms of HbA1c values?
- What are the connections between coping mechanisms of nurses and the adherence of their patients to prescribed treatment regimes?
- What kind of coping strategies help nurses to feel better psychologically and be more satisfied with their job while working with Type 2 Diabetes Mellitus patients?
- How does the implementation of stress and coping mechanisms training affect patients' perception of the quality of the care provided and communication with nurses?
- Can psychological training programs have an impact on health care delivery and patient outcomes among Type 2 Diabetes Mellitus patients in the Hail Region?
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and persistent hyperglycemia, which can lead to severe complications if not effectively managed. Nurses play a crucial role in patient education, self-management support, and promoting adherence to treatment plans; however, psychological stress and inadequate coping mechanisms among nurses can negatively impact the quality of care and patient outcomes. This study aimed to evaluate the effectiveness of a psychological stress and coping mechanism training program for nurses and its impact on glycemic control among patients with T2DM in the Hail Region, Saudi Arabia. A quasi-experimental design was utilized, involving nurses who participated in a structured training program focusing on emotional regulation, stress management, and coping strategies, while patients under their care were monitored for glycemic control using HbA1c and fasting blood glucose levels before and after the intervention. Findings demonstrated that nurses who completed the training program exhibited improved stress management, coping abilities, and patient communication skills, which corresponded with significant improvements in patient glycemic outcomes, including better HbA1c levels and adherence to self-management practices. The study concludes that implementing psychological stress and coping mechanism training for nurses has a positive and substantial effect on both nurse well-being and patient glycemic control, highlighting the importance of integrating such programs into nursing practice to enhance patient-centered care and chronic disease management in the Hail Region.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Maryam Saud Al Shammari, Doctorate
- Numéro de téléphone: +966 55 321 0769
- E-mail: maryamsaud.phdscholar@lincoln.edu.my
Lieux d'étude
-
-
Ha'il Region
-
Ha'il, Ha'il Region, Arabie Saoudite, 53224
- Hail Health Cluster
-
Contact:
- Saad Abdullah Alrasheed, Doctorate
- Numéro de téléphone: +966 55 3217877
- E-mail: IRB-HAIL@MOH.GOV.SA
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Registered nurses hold active registration, will be directly involved in the care of patients with T2DM, were willing to attend all training sessions, and will be available for follow-up assessments.
- Patients will be adults with a confirm diagnosis of T2DM who will be followed up by a participating nurse and who provide informed consent.
Exclusion Criteria:
- Nurses on long-term leave, those not involved in direct patient care, and those who had previously completed a comparable stress-management program.
- Patients with comorbidities known to substantially affect glycemic control, or who were unable to complete the assessments.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Non randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Double
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Experimental: Stress and Coping Training
Nurses will receive the 16-hour Psychological Stress and Coping Mechanism Training Program in four 4-hour sessions plus monthly follow-up, training manual and coping journals. |
The intervention will be grounded in the Transactional Model of Stress and Coping (Lazarus and Folkman, 1984) and in Self-Efficacy Theory (Bandura, 1977). It will comprise 16 hours of face-to-face training delivered in four 4-hour sessions by the principal investigator, a registered nurse educator with training in stress management, to groups of nurses at the participating facilities. Module 1 will address the nature of psychological stress in nursing, common stressors in diabetes care, and early signs of burnout. Module 2 will cover problem-focused and emotion-focused coping and will introduce mindfulness, relaxation, cognitive restructuring, and time-management techniques. Module 3 will examine how nurse stress may affect patient communication, adherence, self-management, and glycemic control, using case studies of nurse-patient interactions. Module 4 will focus on practical skills through role-play, simulated clinical scenarios, group problem-solving, and the use of stress logs and |
|
Aucune intervention: No Intervention: Usual Care
Nurses will continue routine nursing care for patients with Type 2 Diabetes Mellitus without the training program. Patients will receive standard diabetes care and follow-up. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Baseline Demographic and Professional Characteristics of Participating Nurses
Délai: Baseline, pre-intervention [Day 0, first face-to-face interview]
|
Demographic and professional characteristics collected using a researcher-designed form, including: gender, age group, marital status, educational level in nursing, years of nursing experience, job position, and nationality. |
Baseline, pre-intervention [Day 0, first face-to-face interview]
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived stress
Délai: Pretest, immediate post-test, and follow-up three months
|
Nurses' stress will be measure with the 14-item Perceived Stress Scale (PSS- 14; Cohen et al., 1983). Items are rated from 0 (never) to 4 (very often) with reference to the past month. The seven positively worded items (perceived self-efficacy/control) will be reverse score, and all items will be sum to give a total score from 0 to 56, with higher scores indicating greater stress. Subscale scores were computed for helplessness (seven negatively worded items, 0-28) and perceived self-efficacy/control (seven positively worded items, raw scoring, 0-28; higher scores indicating greater perceived control). |
Pretest, immediate post-test, and follow-up three months
|
|
Coping strategies
Délai: Pretest, immediate post-test, and follow-up three months
|
Coping will be measure with the 29-item revised Ways of Coping Checklist (WCCL; Vitaliano et al., 1985), which comprises five subscales: problem-focused coping (12 items), seeking social support (3 items), self-blame (3 items), wishful thinking (6 items), and avoidance (5 items). Items are rated from 1 (not at all) to 4 (to a great extent). |
Pretest, immediate post-test, and follow-up three months
|
|
Diabetes self-management self-efficacy
Délai: Pretest, immediate post-test, and follow-up three months
|
Patients will be complete the 20-item Diabetes Management Self-Efficacy Scale (DMSES; van der Bijl et al., 1999), which covers blood glucose monitoring (3 items), dietary control (10 items), physical activity (3 items), foot care (1 item), and medication intake and follow-up (3 items). Items are rated from 0 (cannot do at all) to 10 (certainly can do); total scores range from 0 to 200, with higher scores indicating greater self-efficacy, and were classified as low (<120), moderate (120-149), or high (≥150). |
Pretest, immediate post-test, and follow-up three months
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- 2026 - 6
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .